A novel immunological model for the study of prostate cancer

Cancer Research

Volumn 59, Issue 10, 1999, Pages 2271-2276

  Sharma, Navesh ^a   Luo, Jun ^a   Kirschmann, Dawn A ^a   O'Malley, Yunxia ^a   Robbins, Michael E C ^a   Akporiaye, Emmanuel T ^b   Lubaroff, David M ^a   Heidger, Paul M ^a   Hendrix, Mary J C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL COUNT; CELL ISOLATION; CELL LINE; CELL STRUCTURE; CELL VIABILITY; FLOW CYTOMETRY; IMMUNOMODULATION; IMMUNOTHERAPY; MALE; MODEL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; RAT; SPONGE (PORIFERA); TUMOR CELL CULTURE; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; CELL SEPARATION; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; INTERLEUKIN-10; LEUKOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHENOTYPE; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RATS; SURGICAL SPONGES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033563001     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Dunning, W. F. Prostate cancer in the rat. Monogr. Natl. Cancer Inst., 12: 351-369, 1963.
2. Isaacs, J. T. The R-3327 system of rat prostatic cancers. Urol. Oncol., 2: 115-116, 1996.
3. Luo, J., Sharma, N., Seftor, E. A., DeLarco, J. E., Heidger, P. M., Hendrix, M. J. C., and Lubaroff, D. M. Heterogeneous expression of invasive and metastatic properties in a prostate tumor model. Pathol. Oncol. Res., 3: 264-271, 1997.
4. Shresta, S., Pham, C. T. N., Thomas, D. A., Graubert, T. A., and Ley, T. J. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol., 10: 581-587, 1998.
5. + T cell responses in antitumor immunity. Curr. Opin. Immunol., 10: 588-594, 1998.
6. Chouaib, S., Asselin-Pature, C., Mami-Chouaib, F., Caignard, A., and Blay, J. Y. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today, 18: 493-497, 1997.
7. Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., and Sobol, R. E. Eradication of established intracranial rat gliomas by transforming growth factor β antisense therapy. Proc. Natl. Acad. Sci. USA, 93: 2909-2914, 1996.
8. Gastl, G. A., Abrams, J. S., Nanus, D. M., Oosterkamp, R., Silver, J., Liu, F., Chen M., Albino, A. P., and Bander, N. H. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer, 55: 96-101, 1993.
9. Maeda, H., and Shiraishi, A. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol., 156: 73-78, 1996.
10. Park, J. A., Brown, R. A., Kurt, R. A., and Akporiaye, E. T. Studies of in vivo recruitment and activation of cytotoxic lymphocytes using a gelatin-sponge model of concomitant tumor immunity. Int. J. Cancer, 62: 421-427, 1995.
11. Akporiaye, E. T., Stewart, S. J., Stevenson, A. P., and Stewart, C. C. A gelatin sponge model for studying tumor growth: flow cytometric analysis and quantitation of leukocytes and tumor cells in the EMT6 mouse tumor. Cancer Res., 45: 6457-6462, 1985.
12. Thompson, S. A., Johnson, M. P., Heidger, P. M., and Lubaroff, D. M. Characterization of the heterogeneity of the R-3327 rat prostatic tumors derived from single-cell clones. Prostate, 6: 369-387, 1985.
13. Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J., and Rifkin, D. B. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem., 216: 276-284, 1994.
14. Picon, A., Gold, L. I., Wang, J., Cohen, A., and Friedman, E. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor β1. Cancer Epidemiol. Biomark. Prev., 7: 497-504, 1998.
15. Wahl, S. M., McCartney-Francis, N., and Mergenhagen, S. E. Inflammatory and immunomodulatory roles of TGF-β. Immunol. Today, 10: 258-261, 1989.
16. Umbas, R., Isaacs, W. B., Bringuier, P. P., Schaafsma, H. E., Karthaus, H. F., Oosterhof, G. O., Debruyne, F. M., and Schalken, J. A. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54: 3929-3933, 1994.